Melanomas of the vulva and vagina

ONCOLOGY

Volumn 10, Issue 7, 1996, Pages 1017-1023

  Trimble, Edward L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AGE; AGED; ANEUPLOIDY; BIOPSY; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHATIC SYSTEM; MELANOMA; METASTASIS; MITOSIS; PATHOLOGY; PROGNOSIS; REVIEW; SALVAGE THERAPY; SURVIVAL RATE; ULCER; VAGINA TUMOR; VULVA TUMOR;

AGE FACTORS; AGED; ANEUPLOIDY; BIOPSY; FEMALE; HUMANS; INTERFERON-ALPHA; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MELANOMA; MITOSIS; NEOPLASM STAGING; PROGNOSIS; SALVAGE THERAPY; SURVIVAL RATE; ULCER; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 0030183281     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Weinstock MA: Malignant melanoma of the vulva and vagina in the United States: Patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 171:1225-1230, 1994.
2. Ragnarsson-Olding B, Johansson H, Rutqvist LE, et al: Malignant melanoma of the vulva and vagina. Cancer 71:1893-1897, 1993.
3. Phillips GL, Bundy BN, Okagaki T, et al: Malignant melanoma of the vulva treated by radical hemivulvectomy: A prospective study of the Gynecologic Oncology Group. Cancer 73:2626-2632, 1994.
4. Podratz KC, Gaffey TA, Symmonds RE, et al: Melanoma of the vulva: An update. Gynecol Oncol 16:153-168, 1983.
5. Rose PG, Piver MS, Tsukada Y, et al: Conservative therapy for melanoma of the vulva. Am J Obstet Gynecol 159:520-525, 1988.
6. Bradgate MG, Rollason TP, McConkey CC, et al: Malignant melanoma of the vulva: A clinicopathological study of 50 women. Br J Obstet Gynecol 97:124-133, 1990.
7. Trimble EL, Lewis JL, Jr., Williams LL, et al: Management of vulvar melanoma. Gynecol Oncol 45:254-258, 1992.
8. Scheistroen M, Trope C, Koern J, et al: Malignant melanoma of the vulva: evaluation of prognostic factors with emphasis on DNA poloidy in 75 patients. Cancer 75:72-80, 1995.
9. McNeer G, Das Gupta TK: Prognosis in malignant melanoma. Surgery 56:512, 1964.
10. Beahrs OH, Myers MH: Manual for Staging of Cancer, American Joint Committee on Cancer, p 117. Philadelphia, JB Lippincott, 1983.
11. FIGO: Changes in gynecologic staging by the International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol 162:180-189, 1990.
12. UICC: TNM Atlas: Illustrated Guide to the TNM/PTNM Classification of Malignant Tumors, 3rd ed. Berlin, Springer, 1990.
13. Clark WH, Jr., From L, Bernardino EA, et al: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705-726, 1969.
14. Beslow A: Thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172:902-908, 1970.
15. Chung AF, Woodruff JM, Lewis JL, Jr: Malignant melanoma of the vulva: A report of 44 cases. Obstet Gynecol 45:638-646, 1975.
16. Reid GC, Schmidt RW, Roberts JA, et al: Primary melanoma of the vagina: A clinicopathologic analysis. Obstet Gynecol 74:190-199, 1989.
17. Tasseron EWK, van der Esch EP, Hart AAM, et al: A clinicopathological study of 30 melanomas of the vulva. Gynecol Oncol 46:170-175, 1992.
18. Davidson T, Kissin M, Westbury G: Vulvo-vaginal melanoma-should radical surgery be abandoned? Br J Obstet Gynecol 94:473-476, 1987.
19. Van Nostrand KM, Lucci JA, Schell M, et al: Primary vaginal melanoma: Improved survival with radical pelvic surgery. Gynecol Oncol 55:234-237, 1994.
20. Balch CM, Urist MM, Karakousis CP, et al: Efficacy of 2-cm surgical margins for intermediate thickness melanomas (1-4 mm): Results of a multi-institutional randomized surgical trial. Ann Surg 218:262-269, 1993.
21. Veronesi U, Cascinelli N: Narrow excision (1 cm margin): A safe procedure for thin cutaneous melanoma. Arch Surg 126:438-41, 1991.
22. Urist MM, Balch CM, Soong SJ, et al: The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer 55:1398-1402, 1985.
23. Slingluff CL, Stidham KR, Ricci WM, et al: Surgical management of regional lymph nodes in patients with melanoma: Experience with 4682 patients. Ann Surg 219:120-130, 1994.
24. Balch CM, Soong SJ, Milton GW et al: A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196:677-684, 1982.
25. Milton GW, Shaw HM, McCarthy WH, et al: Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patients. Br J Surg 69:108-111, 1982.
26. Reintgen DS, Cox EB, McCarty KS, Jr, et al: Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 198:379-385, 1983.
27. Cascinelli N, Belli F: Treatment of regional nodes. Semin Surg Oncol 8:370-373, 1992.
28. Sim FH, Tayor WF, Pritchard DJ, et al: Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study Mayo Clin Proc 61:697-705, 1986.
29. Fisher SR, Cole TB, Segler HF, et al: Application of posterior neck dissection in treating malignant melanoma of the posterior scalp. Laryngoscope 93:760-765, 1983
30. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperarive lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992.
31. Levenback C, Burke TW, Gershenson DM, et al: Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 84:163-167, 1994.
32. van der Veen H, Hoekstra OS, Paul MA, et al: Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 81:1769-1770, 1994.
33. Krag DN, Meijer SJ, Weaver DL, et al: Minimal-access surgery for staging of malignant melanoma. Arch Surg 130:654-658, 1995.
34. Thornes RD, Daly L, Lynch G, et al: Treatment with coumarin to prevent or delay recurrence of malignant melanoma (suppl). J Cancer Res Clin Oncol 120:S32-S34, 1994.
35. Ghussen F, Kruger I, Smalley RV, et al: Hyperthermic perfusion with chemotherapy for melanoma of the extremities. World J Surg 13:598-602, 1989.
36. Kirkwood JM, Strawderman MH, Ernstoff MS, et al: Interferon alfa-2b adjuvant therapy of high-risk cutaneous melanoma; the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 14:7-17, 1996.
37. Pritchard KI, Quirt IC, Cowan DH, et al: DTIC therapy in metastatic malignant melanoma: A simplified dose schedule. Cancer Treat Rep 64:1123, 1989.